Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Publications Article
![]()
This is a selection made from among articles on Drug Treatment Publications. For a permanent link to this article, or to bookmark it for future reading, click here.
Teens Drugs Rehab Programs
from: Drug abuse by teenagers is very common problem of Today that can lead to terrible consequences in the future. A large percentage of deaths in public between 15 and 25 are apparently associated in some way or the other to drug or alcohol abuse. Such abuse also direct to violent criminal acts, such as stabbing, murder or rape. Some teenagers also take drugs to conquer depression and nervousness.One main goal of any drug rehab is to create and atmosphere where a patient can feel relaxed enough to be honest and not feel judged. 40% of teens say they thinkto use a drug in the future. One out of every five kids in eighth grade has already tried marijuana.
If a teenager unexpectedly starts behaving in an abnormal manner or tries to keep detached from others, it means you have reasons to be doubtful. Physical signs such as red eyes, niggling cough, and changes in eating and sleeping behavior should also serve as warning signals.
A teen with a family background of drug use and short of societal skills can turn quickly from the level of trailing to grave abuse or enslavement. Some other teenagers, who have no family history of such abuse, may also arrive at the level of absolute dependency. Although any guess is almost not possible, teenagers with a family history of alcohol or drug abuse should specially abstain and exhortation from experimenting.
The user's concern with drugs, plus its effects on mood and presentation, can lead to poor presentation in schools, colleges or workplaces, resultant in firing. A teen’s drug abuse can ravage parents and other family members, and spoil family life. According to a Survey on Substance Abuse teens and their parents view drugs as their biggest concern.
The effects of different types of drugs on teens include tetchiness, insomnia, seizures, anxiety, paranoia, antagonism, memory loss, learning problems, increased heart rate, lethargy, panic attacks, symptoms of continual bronchitis, daily coughs and phlegm, more common chest colds, muscle tension, teeth clenching, dehydration, hypothermia, brain damage, and death.
There are also a number of considerations to ponder when choosing a facility for your or your loved one's treatment
· Complete Continuum of Care
· Detoxification through Extended Care
· Post-Residential Care
· Availability of Medical Staff
· Program Flexibility
For help go to following:
http://www.restoringtroubledteens.com/
http://www.troubledteens4jesus.com/
http://www.restoretroubledteens.com/
Restoring Troubled Teens is a Directory Listing of Schools and Articles specifically designed to support the parents of Troubled Teens. Restore Troubled Teens are worked for teens based on teens suicide, teens violence, adolescence, etc.
About Author
About Author: Nivea David
For listings please visit http://www.troubledteens4jesus.com/ Troubled Teens Help.You can also visit http://www.restoringtroubledteens.com/ for Juvenile Justice System . And http://www.restoretroubledteens.com/ for Residential Treatment Centers .
Source: ArticleTrader.com
Drug Treatment Publications Specific links
Drug Treatment Publications News
Guest Post: Data, Drugs, And Deception-- A True Story - Forbes
Guest Post: Data, Drugs, And Deception-- A True Story Forbes Their findings disagree with an analysis published in 2010 in theArchives of Internal Medicine, and with analyses from two equally respected publications, theTherapeutics Letter and the Cochrane Collaboration.* Despite this history of dueling data the ... |
Marijuana users want Arizona to expand drug's medical use - East Valley Tribune
Marijuana users want Arizona to expand drug's medical use East Valley Tribune Elaine Burns, a licensed naturopathic physician, testifies Friday at a Health Department hearing that marijuana has potential for treating post-traumatic stress disorder, particularly since the alternative for sufferers often is self-medicating with ... |
The Overall Psoriasis Drug Market Will Increase from $4.1 Billion in 2010 to ... - MarketWatch (press release)
The Overall Psoriasis Drug Market Will Increase from $4.1 Billion in 2010 to ... MarketWatch (press release) BURLINGTON, Mass., May 21, 2012 (BUSINESS WIRE) -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of moderate to severe psoriasis, ... |
Docs slower to drop 'black box' drugs, adopt new therapies, when access to ... - MarketWatch (press release)
Docs slower to drop 'black box' drugs, adopt new therapies, when access to ... MarketWatch (press release) This longer response time holds true whether the physicians are responding to "positive news" related to an innovative therapy or "negative news" related to a newly discovered medicine risk. The report, "Can Access Limits of Sales Representatives to ... |
Raptor Pharmaceutical Announces Publication of Phase 3 Results in the Clinical ... - MarketWatch (press release)
Raptor Pharmaceutical Announces Publication of Phase 3 Results in the Clinical ... MarketWatch (press release) Also in March, Raptor submitted a New Drug Application ("NDA") to the US Food and Drug Administration ("FDA") seeking approval to market RP103 for the potential treatment of nephropathic cystinosis. Raptor requested a Priority Review of the NDA which, ... |
Cellceutix Files Amended IND With FDA for Its Novel p53 "Guardian Angel" Anti ... - MarketWatch (press release)
Cellceutix Files Amended IND With FDA for Its Novel p53 "Guardian Angel" Anti ... MarketWatch (press release) BEVERLY, MA, May 21, 2012 (MARKETWIRE via COMTEX) -- Cellceutix Corporation (OBB:CTIX) (the "Company"), a biopharmaceutical company developing a novel drug to treat cancers and cancers which have proven resistant to today's cancer therapies ... Cellceutix Files Amended IND With FDA for Its Novel p53 Guardian Angel Anti ... |
Optogenetics project takes top NIDA Addiction Science Award - National Institutes of Health (press release)
Optogenetics project takes top NIDA Addiction Science Award National Institutes of Health (press release) A project that maps dopamine circuits in the prefrontal cortex through optogenetic manipulation was given top honors in this year's annual Addiction Science Awards at the 2012 Intel International Science and Engineering Fair (ISEF) — the world's ... |
Viral Genetics' P-IND Clears FDA To Commence Clinical Trials in Humans - MarketWatch (press release)
Viral Genetics' P-IND Clears FDA To Commence Clinical Trials in Humans MarketWatch (press release) It will examine the safety and efficacy of one of Viral Genetics licensed MDT compounds in combination with an existing cancer drug, sorafenib (marketed as Nexavar(TM)) in the treatment of patients resistant or otherwise unsuitable for standard ... |
Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug ... - MarketWatch (press release)
Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug ... MarketWatch (press release) The publication includes data from preclinical models that highlight the selectivity and pharmacokinetic profile of the drug candidate. The manuscript published in Molecular Cancer Therapeutics describes the pharmacokinetic profile and anti-tumor ... |
Concerns over Drug Resistance in Gram-Negative Infections Has Led to the ... - MarketWatch (press release)
Concerns over Drug Resistance in Gram-Negative Infections Has Led to the ... MarketWatch (press release) Additionally, 80 percent of surveyed physicians report prescribing a combination of anti-pseudomonal drugs to treat infections due to P. aeruginosa. As compared to other key GNI therapies, ID specialists rate the carbapenems higher on overall ... |

